| Nauck M, Smith U
Incretin-based therapy: how do incretin mimetics and DPP-4 inhibitors fit into treatment algorithms for type 2 diabetic patients? [Journal Article]
Best Pract Res Clin Endocrinol Metab 2009 Aug; 23(4):513-23.
Abstract | Full Citation |
| Irwin N, Flatt PR
Therapeutic potential for GIP receptor agonists and antagonists. [Journal Article, Research Support, Non-U.S. Gov't]
Best Pract Res Clin Endocrinol Metab 2009 Aug; 23(4):499-512.
Abstract | Full Citation |
| Ahrén B
Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin--diabetes control and potential adverse events. [Journal Article]
Best Pract Res Clin Endocrinol Metab 2009 Aug; 23(4):487-98.
Abstract | Full Citation |
| Thornberry NA, Gallwitz B
Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4). [Journal Article]
Best Pract Res Clin Endocrinol Metab 2009 Aug; 23(4):479-86.
Abstract | Full Citation |
| Madsbad S
Exenatide and liraglutide: different approaches to develop GLP-1 receptor agonists (incretin mimetics)--preclinical and clinical results. [Journal Article]
Best Pract Res Clin Endocrinol Metab 2009 Aug; 23(4):463-77.
Abstract | Full Citation |
| Vilsbøll T, Holst JJ, Knop FK
The spectrum of antidiabetic actions of GLP-1 in patients with diabetes. [Journal Article]
Best Pract Res Clin Endocrinol Metab 2009 Aug; 23(4):453-62.
Abstract | Full Citation |
| Mentlein R
Mechanisms underlying the rapid degradation and elimination of the incretin hormones GLP-1 and GIP. [Journal Article]
Best Pract Res Clin Endocrinol Metab 2009 Aug; 23(4):443-52.
Abstract | Full Citation |
| Meier JJ
The contribution of incretin hormones to the pathogenesis of type 2 diabetes. [Journal Article]
Best Pract Res Clin Endocrinol Metab 2009 Aug; 23(4):433-41.
Abstract | Full Citation |
| Deacon CF, Holst JJ
Immunoassays for the incretin hormones GIP and GLP-1. [Journal Article]
Best Pract Res Clin Endocrinol Metab 2009 Aug; 23(4):425-32.
Abstract | Full Citation |
| Ma J, Rayner CK, Jones KL, et al.
Insulin secretion in healthy subjects and patients with Type 2 diabetes--role of the gastrointestinal tract. [Journal Article, Research Support, Non-U.S. Gov't]
Best Pract Res Clin Endocrinol Metab 2009 Aug; 23(4):413-24.
Abstract | Full Citation |
  |
